CSIMarket


Merrimack Pharmaceuticals Inc  (NASDAQ: MACK)
Other Ticker:  
 

Merrimack Pharmaceuticals Inc

MACK's Fundamental analysis








Merrimack Pharmaceuticals Inc's sales fell in the first quarter of 2024 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded growth of revenues by 0.35 %



More on MACK's Growth


Merrimack Pharmaceuticals Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Merrimack Pharmaceuticals Inc PEG ratio is at -0 Company is currently trading with Price to Cash flow multiple of 1.02 in trailing twelve-month period.
Company
1.09
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.14.


More on MACK's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ 1,721,111
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 15.34

Merrimack Pharmaceuticals Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Merrimack Pharmaceuticals Inc PEG ratio is at -0 Company is currently trading with Price to Cash flow multiple of 1.02 in trailing twelve-month period.
Company
1.09
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.14.

Merrimack Pharmaceuticals Inc Price to Book Ratio is at 0.99 lower than Industry Avg. of 110.91. and higher than S&P 500 Avg. of 0.02

More on MACK's Valuation

  Market Capitalization (Millions $) 219
  Shares Outstanding (Millions) 14
  Employees 117
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) 201
  Cash Flow (TTM) (Millions $) 215
  Capital Exp. (TTM) (Millions $) -
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ 1,721,111
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) 15.34

  Market Capitalization (Millions $) 219
  Shares Outstanding (Millions) 14
  Employees 117
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) 201
  Cash Flow (TTM) (Millions $) 215
  Capital Exp. (TTM) (Millions $) -





  Ratio
   Capital Ratio (MRQ) 10.78
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.1
  Asset Turnover Ratio (TTM) -
  Inventory Turnover Ratio (TTM) -





Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.